Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |